Abstract:It is now well-established that mesenchymal stem/stromal cells (MSCs) have potent tissue reparative/regenerative properties, and also exert profound anti-inflammatory and immunomodulatory effects. However, despite the abundant basic science and preclinical data highlighting the immense therapeutic potential of MSCs, we still lack an understanding of the true extent of the clinically beneficial effects of MSCs. This deficit in our clinical knowledge is due in large part to the fact that MSCs lack of effectors of cell migration, and, therefore, MSCs are incapable of parenchymal colonization at injured/inflamed tissues following the intravascular administration. In this regard, it is important to distinguish tissue "entrapment" from authentic tissue "recruitment" (also known as tissue "homing"). Entrapment, as the word implies, occurs as a consequence of these large cells (upwards of 20 μm in diameter) being distributed throughout the body in a stochastic fashion, a result of being terminally wedged within the lumen of microvessels. This microvascular lodgment occurs more frequently within sites of inflammation due to inflammation-induced vasodilation and increased blood flow to the affected tissue (the pathobiology of "rubor"). It thus may appear that MSCs possess the capacity to "seek" inflammatory sites, leading some investigators to comingle, inappropriately, the passive process of MSC tissue entrapment with the physiologically distinct, extravasation-dependent, process of tissue recruitment. In contrast to entrapment, tissue recruitment is a site-specific, active/metabolic process whereby the circulating cells expressly adhere to the target tissue endothelial cells and thereafter extravasate (this ability to cross the endothelial barrier is known as "transendothelial migration" or "transmigration"), with consequent parenchymal infiltration. The major advantage of parenchymal colonization is that MSCs release their payload of biologically active agents within the tissue itself, optimizing their capacity to sense the tissue microenvironment with the subsequent release of pertinent beneficial growth factors. In this fashion, MSCs can most effectively function in a paracrine/trophic manner, consistent with the conceptual acronym of the "MSC" being a "Medicinal Signaling Cell" as proffered by the late, pioneering, MSC investigator Dr. Arnold I. ("Arnie") Caplan. 1 Thus, the tissue-infiltrating MSC becomes a biologic factory in situ , whereas the released paracrine/trophic payload of an entrapped MSC is washed downstream by blood flow.

Effect of the Microenvironment on Mesenchymal Stem Cell Paracrine Signaling: Opportunities to Engineer the Therapeutic Effect

Effects of Mesenchymal Stem Cell‐Derived Paracrine Signals and Their Delivery Strategies

Engineering microenvironments towards harnessing pro-angiogenic potential of mesenchymal stem cells

Effect of 2D and 3D Culture Microenvironments on Mesenchymal Stem Cell-Derived Extracellular Vesicles Potencies

Engineering the MSC Secretome: A Hydrogel Focused Approach

Three-Dimensional Mechanical Microenvironment Enhanced Osteogenic Activity Of Mesenchymal Stem Cells-Derived Exosomes

Biomaterials Functionalized with MSC Secreted Extracellular Vesicles and Soluble Factors for Tissue Regeneration

Bioprocessing of Mesenchymal Stem Cells and Their Derivatives: Toward Cell-Free Therapeutics

Cellular expansion of MSCs: Shifting the regenerative potential

Enhancement of therapeutic potential of mesenchymal stem cell-derived extracellular vesicles

Physical modulation of mesenchymal stem cell exosomes: A new perspective for regenerative medicine

Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy

Substrate mechanical properties bias MSC paracrine activity and therapeutic potential

Readaptation of mesenchymal stem cells to high stiffness and oxygen environments modulate the extracellular matrix

Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cell-Free Therapy

Mesenchymal Stem/Stromal Cells and Their Paracrine Activity-Immunomodulation Mechanisms and How to Influence the Therapeutic Potential

Matrix Composition and Mechanics Direct Proangiogenic Signaling from Mesenchymal Stem Cells

Recent Progress in Engineering Mesenchymal Stem Cell Differentiation

Harnessing the Properties of Biomaterial to Enhance the Immunomodulation of Mesenchymal Stem Cells

Enforced HCELL expression: empowering "Step 1" to optimize the efficacy of mesenchymal stem/stromal cell therapy for stroke and other clinical conditions

Paracrine Effects Influenced by Cell Culture Medium and Consequences on Microvessel-Like Structures in Cocultures of Mesenchymal Stem Cells and Outgrowth Endothelial Cells